NeOnc President Adds Shares
Denver, Colorado- A fresh insider signal just hit the tape for NeOnc Technologies Holdings (NASDAQ:NTHI), and it’s the kind of move traders tend to notice.
According to a recent SEC Form 4 filing, company president Amir F. Heshmatpour purchased 10,000 additional shares, increasing his personal stake in the clinical-stage biotech. NeOnc is currently advancing multiple Phase 2 programs focused on treating central nervous system (CNS) cancers, one of the most challenging and high-need areas in oncology.
Insider buying doesn’t guarantee upside, but it often reflects internal conviction. When an executive with direct visibility into development timelines and clinical progress steps in to add shares, it can serve as a quiet vote of confidence, especially in early-stage biotech.